Molecular Evidence of Rejection Intervention Trial

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
MERIT is a double-blind, multi-center, placebo-controlled, randomized clinical trial. Heart transplant recipients with dual-positive GEP/dd-cfDNA assays with a corresponding negative biopsy between 2 months and 2 years post-transplant will be randomized to treatment with either high-dose oral steroids or placebo, in addition to standard of care therapy.
Epistemonikos ID: 72d33cdaebd606b828cd380936603a2192c3b441
First added on: Oct 30, 2026